Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?

Panteleimon E. Papakonstantinou; Josip A. Borovac; Aleksandra Gasecka; Dario Bongiovanni; Hanne Ehrlinder; Michela Giustozzi; William A. E. Parker; Rui Azevedo Guerreiro

doi:10.1093/eurjpc/zwab021

Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?

Panteleimon E. Papakonstantinou^*
, Josip A. Borovac
, Aleksandra Gasecka
, Dario Bongiovanni
, Hanne Ehrlinder
, Michela Giustozzi
, William A. E. Parker
, Rui Azevedo Guerreiro

^*Corresponding author for this work

Evagelismos Hospital
National and Kapodistrian University of Athens
Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia
Medical University of Warsaw
Klinik und Poliklinik Innere Medizin I (Kardiologie, Angiologie und Pneumologie), Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
German Centre for Cardiovascular Research
IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
Karolinska Institutet
University of Perugia
University of Sheffield
Hospital do Espirito Santo - Evora, EPE, Portugal

Research output: Contribution to journal › Comment/Letter to the editor › Academic

29 Downloads (Pure)

Original language	English
Article number	zwab021
Journal	European journal of preventive cardiology
Early online date	2021
DOIs	https://doi.org/10.1093/eurjpc/zwab021
Publication status	E-pub ahead of print - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/eurjpc/zwab021

Anticoagulation-therapy-in-non-valvular-atrial-fibrillation-in-the-covid-19-era.pdfFinal published version, 289 KBLicence: Taverne

Cite this

Papakonstantinou, P. E., Borovac, J. A., Gasecka, A., Bongiovanni, D., Ehrlinder, H., Giustozzi, M., Parker, W. A. E., & Guerreiro, R. A. (2021). Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy? European journal of preventive cardiology, Article zwab021. Advance online publication. https://doi.org/10.1093/eurjpc/zwab021

@article{1cac36a282444849b5e329576e725914,

title = "Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?",

author = "Papakonstantinou, \{Panteleimon E.\} and Borovac, \{Josip A.\} and Aleksandra Gasecka and Dario Bongiovanni and Hanne Ehrlinder and Michela Giustozzi and Parker, \{William A. E.\} and Guerreiro, \{Rui Azevedo\}",

year = "2021",

doi = "10.1093/eurjpc/zwab021",

language = "English",

journal = "European journal of preventive cardiology",

issn = "2047-4873",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era

T2 - Is it time to reconsider our therapeutic strategy?

AU - Papakonstantinou, Panteleimon E.

AU - Borovac, Josip A.

AU - Gasecka, Aleksandra

AU - Bongiovanni, Dario

AU - Ehrlinder, Hanne

AU - Giustozzi, Michela

AU - Parker, William A. E.

AU - Guerreiro, Rui Azevedo

PY - 2021

Y1 - 2021

UR - https://www.scopus.com/pages/publications/85114910640

U2 - 10.1093/eurjpc/zwab021

DO - 10.1093/eurjpc/zwab021

M3 - Comment/Letter to the editor

C2 - 33564838

SN - 2047-4873

JO - European journal of preventive cardiology

JF - European journal of preventive cardiology

M1 - zwab021

ER -

Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?

UN SDGs

Access to Document

Other files and links

Cite this